Safety and Efficacy of the SurVeilâ„¢ Drug-Coated Balloon (TRANSCEND)

What is the purpose of this trial?

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries.

Participation Guidelines

Ages: 18 years and older

Gender: Both

SurModics, Inc.

Start Date: 03/30/2018

End Date: 04/30/2020

Last Updated: 04/06/2018

Study HIC#: 2000021726

Get Involved

For more information about this study, contact:
Jacqueline Gamberdella
+1 203-737-1899

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Carlos Mena

Principal Investigator